相关实验视频
Updated: Jun 10, 2025

05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
13.1K
关于动脉样硬化斑块形成和进展的免疫学观点
Hui Pi1,2, Guangliang Wang1, Yu Wang1
1Affiliated Qingyuan Hospital, Guangzhou Medical University (Qingyuan People's Hospital), Qingyuan, Guangdong, China.
Frontiers in immunology
|October 14, 2024
概括
免疫系统,包括先天和适应性反应,显著影响动脉样硬化进展. 了解这种复杂的相互作用为打击心血管疾病提供了新的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管生物学 心血管生物学
- 进化医学是一种进化医学.
背景情况:
- 动脉样硬化是心血管疾病的主要原因之一.
- 免疫反应与动脉样硬化斑块发展的所有阶段有关.
- 天生的免疫和适应性免疫都在动脉生成中发挥着关键作用.
研究的目的:
- 审查动脉样硬化斑块演变中的关键免疫反应.
- 通过进化免疫生物学的镜头来研究动脉样硬化.
- 为了阐明斑块进化和免疫之间的相互作用.
主要方法:
- 文献综述专注于免疫系统参与动脉样硬化.
- 对天生的免疫细胞 (中性粒细胞,单细胞/巨细胞,树突细胞) 和适应性免疫细胞 (T细胞,B细胞) 的分析.
- 检查模式识别受体,炎症媒介和细胞因子在动脉生成中的作用.
主要成果:
- 天生的免疫细胞和炎症调解剂有助于斑块的形成.
- 适应性免疫反应,包括T细胞和B细胞,调节疾病活动.
- 白血球亚种群的异质性在斑块进化中至关重要.
- 技术的进步揭示了免疫参与的详细机制.
结论:
- 免疫反应是动脉样硬化斑块进化的组成部分.
- 进化免疫生物学的观点加深了我们对动脉样硬化的理解.
- 了解斑块免疫相互作用可以指导动脉样硬化症治疗策略.
相关概念视频
Atherosclerosis I: Introduction
2
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2
Inflammation
53.0K
Overview
53.0K
Coronary Artery Disease II: Pathophysiology
3
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
3
Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Atherosclerosis II: Clinical manifestations and prevention
2
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
2
Coronary Artery Disease I: Introduction
3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3

